Rare diseases
Investigational molecules
Locations
A Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis
ItalyA study to evaluate the effects of BI 764198 in adults and adolescents with focal segmental glomerulosclerosis (FSGS)
ItalyA Study Comparing Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy
ItalyA study testing molnupiravir in adults with COVID-19 who are not hospitalized and are at high risk for serious illness
ItalyA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
ItalyA study comparing XL092 versus everolimus in patients with previously treated advanced or metastatic neuroendocrine tumors
ItalyStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
ItalyA Study of Ivonescimab Combined with Fluorouracil, Folinic Acid, and Oxaliplatin Compared to Bevacizumab for Patients with Metastatic Colorectal Cancer
ItalyStudy of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo
ItalyStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
ItalyStudy of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis
ItalyStudy of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
